CELL-MEDIATED RESPONSES TO TUMOR XENOGRAFTS IN MICE

CELL-MEDIATED RESPONSES TO TUMOR XENOGRAFTS IN MICE

Detalhes bibliográficos
Principais autores:	Simpson, E, Beverley, P
Formato:	Journal article
Publicado em:	1972

Registros relacionados

Cell-mediated responses to tumour xenografts in mice.
por: Simpson, E, et al.
Publicado em: (1972)

HUMORAL RESPONSES TO TUMOUR XENOGRAFTS IN ALS-TREATED MICE
por: Beverley, P, et al.
Publicado em: (1970)

Humoral responses to tumour xenografts in ALS-treated mice.
por: Beverley, P, et al.
Publicado em: (1970)

Lymphocyte-dependent antibody in a tumor xenograft system.
por: Simpson, E, et al.
Publicado em: (1973)

CYTOTOXIC ACTIVITY IN-VITRO OF THYMUS-DERIVED LYMPHOCYTES SENSITIZED TO XENOGRAFT ANTIGENS
por: Beverley, P, et al.
Publicado em: (1972)

Cytotoxic activity in vitro of thymus-derived lymphocytes sensitized to xenograft antigens.
por: Beverley, P, et al.
Publicado em: (1972)

The histological response to a xenogeneic tumour in mice.
por: Simpson, E, et al.
Publicado em: (1973)

Tracking Tumor Cells in Lymphatics in a Mice Xenograft Model by Magnetic Resonance Imaging
por: Ting Liu, et al.
Publicado em: (2012-11-01)

Lycopene in Combination With Sorafenib Additively Inhibits Tumor Metastasis in Mice Xenografted With Lewis Lung Carcinoma Cells
por: Ya-Ping Chan, et al.
Publicado em: (2022-05-01)

Xenograft Tumor Growth Assay
por: Li-Ting Wang, et al.
Publicado em: (2013-10-01)

Integrated genomics of ovarian xenograft tumor progression and chemotherapy response
por: Raphael Benjamin J, et al.
Publicado em: (2011-07-01)

Tumor Rejection Effects of Allorestricted Tumor Peptide-Specific CD4 T Cells on Human Cervical Cancer Cell Xenograft in Nude Mice
por: Yinhong Song, et al.
Publicado em: (2012-07-01)

Tumor xenograft animal models for esophageal squamous cell carcinoma
por: Nikki P. Lee, et al.
Publicado em: (2018-08-01)

Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts
por: A. Capasso, et al.
Publicado em: (2019-02-01)

Establishment of Patient-Derived Xenografts in Mice
por: Dongkyoo Park, et al.
Publicado em: (2016-11-01)

Cultured circulating tumor cells and their derived xenografts for personalized oncology
por: Ruoxiang Wang, et al.
Publicado em: (2016-10-01)

Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus.
por: Kui Chen, et al.
Publicado em: (2012-01-01)

Pharmacokinetic Analysis of 64Cu-ATSM Dynamic PET in Human Xenograft Tumors in Mice
por: Fan Li, et al.
Publicado em: (2015-03-01)

Advances in prostate cancer research models: From transgenic mice to tumor xenografting models
por: Yuejiao Huang, et al.
Publicado em: (2016-04-01)

Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
por: Ekaterina V Blinova, et al.
Publicado em: (2018-01-01)

Camptothecin Delivery via Tumor-Derived Exosome for Radiosensitization by Cell Cycle Regulation on Patient-Derived Xenograft Mice
por: Yiling Yang, et al.
Publicado em: (2022-04-01)

Optimizing Drug Response Study Design in Patient-Derived Tumor Xenografts
por: Jessica Weiss, et al.
Publicado em: (2022-11-01)

Impact of Cancer-Associated Fibroblast on the Radiation-Response of Solid Xenograft Tumors
por: Alizée Steer, et al.
Publicado em: (2019-08-01)

T-SIGn tumor reengineering therapy and CAR T cells synergize in combination therapy to clear human lung tumor xenografts and lung metastases in NSG mice
por: Olmo Sonzogni, et al.
Publicado em: (2022-12-01)

Imaging beta-galactosidase activity in human tumor xenografts and transgenic mice using a chemiluminescent substrate.
por: Li Liu, et al.
Publicado em: (2010-08-01)

Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft Models
por: Yudan Chi, et al.
Publicado em: (2014-01-01)

Characterization of human cancer xenografts in humanized mice
por: Holly K Koblish, et al.
Publicado em: (2020-05-01)

Sema3A drastically suppresses tumor growth in oral cancer Xenograft model of mice
por: Chao Huang, et al.
Publicado em: (2017-07-01)

Application Analysis of 124I-PPMN for Enhanced Retention in Tumors of Prostate Cancer Xenograft Mice
por: Xia L, et al.
Publicado em: (2021-11-01)

Molecular targeting of carbonic anhydrase IX in mice with hypoxic HT29 colorectal tumor xenografts.
por: Sean Carlin, et al.
Publicado em: (2010-05-01)

Patient-derived xenograft model of well-differentiated pancreatic neuroendocrine tumor in immunodeficient Balb/c Nude mice
por: V. S. Trifanov, et al.
Publicado em: (2020-07-01)

Drosophila innate immunity suppresses the survival of xenografted mammalian tumor cells
por: Ayaka Aida, et al.
Publicado em: (2023-07-01)

In vitro reactivity of lymphoid cells from tolerant mice.
por: Beverley, P, et al.
Publicado em: (1973)

Metabolomic and transcriptomic response to imatinib treatment of gastrointestinal stromal tumour in xenograft-bearing mice
por: Szymon Macioszek, et al.
Publicado em: (2023-04-01)

Applications of patient-derived tumor xenograft models and tumor organoids
por: Go J. Yoshida
Publicado em: (2020-01-01)

Circulating tumor cells from melanoma patients show phenotypic plasticity and metastatic potential in xenograft NOD.CB17 mice
por: Claudia Felici, et al.
Publicado em: (2022-07-01)

Lowering of Tumor Interstitial Fluid Pressure Reduces Tumor Cell Proliferation in a Xenograft Tumor Model
por: Matthias Hofmann, et al.
Publicado em: (2006-02-01)

Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer.
por: Christina H Stuelten, et al.
Publicado em: (2010-01-01)

Inhibition and Mechanism of Imatinib on A549 Xenograft Tumor in Nude Mice via PDGF/PDGFR Pathway
por: XIA Bingtian, et al.
Publicado em: (2023-09-01)

Differential Uptake of 18F-fluorodeoxyglucose by Experimental Tumors Xenografted into Immunocompetent and Immunodeficient Mice and the Effect of Immunomodification
por: Marcelo Mamede, et al.
Publicado em: (2003-03-01)